Skidmore, Sophie
Barker, Roger A.
Article History
Received: 11 December 2019
Accepted: 4 November 2022
First Online: 12 January 2023
Competing interests
: R.A.B. offers consultancy advice around cell-based therapies for Parkinson’s disease to Living Cell Technologies, Fujifilm Cellular Dynamics Inc., BlueRock Therapeutics, Novo Nordisk, Cellino Biotech and Aspen Neuroscience. S.S. declares no competing interests.